Development of phenotypic assays for identifying novel blockers of L-type calcium channels in neurons
Abstract L-type calcium channels (LTCCs) are highly expressed in the heart and brain and are critical for cardiac and neuronal functions. LTCC-blocking drugs have a long and successful record in the clinic for treating cardiovascular disorders. In contrast, establishment of their efficacy for indica...
Guardado en:
Autores principales: | Rebecca Hagan, Elizabeth Rex, David Woody, Monika Milewski, Thomas Glaza, Michael P. Maher, Yi Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d47221df885344dc960f53333798321c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Hannan Safiyyah Tan Sian Hui Abdullah, et al.
Publicado: (2021) -
Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Jonne Lintunen, et al.
Publicado: (2021) -
Effect of calcium channel blockers on incidence of diabetes: a meta-analysis
por: Noto H, et al.
Publicado: (2013) -
Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers
por: Jordi Heijman, et al.
Publicado: (2021) -
Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
por: Han Saem Jeong, et al.
Publicado: (2021)